MCC950 is a potent and selective small-molecule inhibitor of the NLRP3 inflammasome, widely utilized in research to investigate the suppression of cytokine release and the modulation of inflammatory pathways.… Read more








MCC950 is a potent and selective small-molecule inhibitor of the NLRP3 inflammasome, widely utilized in research to investigate the suppression of cytokine release and the modulation of inflammatory pathways. As a critical subject in preclinical drug development, MCC950 and its related compounds are essential tools for analytical chemistry. Pharmaceutical laboratories require access to well-characterized reference standards, including identified impurities and metabolites, to ensure robust impurity profiling and method validation during drug development cycles. Stable isotope labelled compounds, such as MCC950-d6, are particularly valuable as internal standards in mass spectrometry-based quantitative analysis, providing the necessary accuracy for tracking pharmacokinetic properties and verifying drug purity. These reference materials facilitate precise analytical testing, enabling researchers to maintain strict quality control standards while studying the therapeutic potential of NLRP3 inhibition in various inflammatory conditions.